Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy [Phase 3]
A Phase 3 trial comparing risankizumab to FUMADERM in adults with moderate to severe plaque psoriasis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp [Phase 3]
Phase 3 trial assessing efficacy and safety of Apremilast (CC-10004) for moderate to severe plaque psoriasis of the scalp; study completed w…
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 dose-ranging trial in moderate to severe plaque psoriasis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial comparing secukinumab to ustekinumab in subjects with plaque psoriasis has completed and posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis [Phase 4]
Phase 4 trial evaluating secukinumab versus placebo on aortic vascular inflammation in moderate to severe plaque psoriasis completed with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
Clinical trial update assessing the efficacy of etanercept over 12 months in routine treatment of rheumatoid arthritis and related inflammat…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis [Phase 2]
Phase 2 trial of a botanical drug (EISO) for mild-to-moderate plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Plaque Psoriasis Efficacy and Safety With Secukinumab [Phase 3]
Phase 3 trial results for secukinumab in plaque psoriasis have been completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine [Phase 2]
Phase 2 trial update exploring sequential treatment of plaque psoriasis using an integrated Traditional Chinese and Western medicine approac…
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy [Phase 2]
Phase 2 efficacy study of CDP870 in chronic plaque psoriasis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME) [Phase 3]
Phase 3 trial update evaluating secukinumab 300 mg in adults with moderate-to-severe plaque psoriasis; completed with posted results in 2019…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of PF-06700841 in moderate-to-severe plaque psoriasis has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy [Phase 4]
Phase 4 clinical trial update evaluating apremilast in patients with plaque psoriasis who are dissatisfied with stable maintenance topical t…
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis [Phase 4]
Phase 4 trial assessing the efficacy and safety of Enstilar Foam in combination with Apremilast (Otezla) for moderate plaque psoriasis; stud…
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating escalating oral doses of itacitinib in patients with plaque psoriasis; study completed.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis [Phase 2]
A Phase 2 trial comparing HAT1 to calcipotriol in mild-to-moderate chronic plaque psoriasis has completed and reports on efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: MSB11022 in Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial update for MSB11022 in moderate to severe chronic plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 trial comparing guselkumab to fumaric acid esters in moderate to severe plaque psoriasis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test [Phase 1]
Phase 1 trial evaluating the potency of SOR007 Ointment for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial comparing BI 695501, a biosimilar, with Humira in moderate to severe chronic plaque psoriasis assessed for efficacy, safety, a…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
This clinical trial update reports on patient adherence attitudes toward scheduled adalimumab maintenance therapy across multiple inflammato…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis [Phase 4]
Phase 4 trial evaluating apremilast 30 mg twice daily in combination with narrowband UVB for plaque psoriasis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients [Phase 2]
Phase 2 study of oral MP1032 in psoriasis patients has completed and results have been posted. The trial evaluated safety and efficacy in pl…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis [Phase 1]
A Phase 1 study evaluating the safety and tolerability of Calcipotriene foam 0.005% in pediatric patients with mild-to-moderate plaque psori…
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: A Long Term Safety Extension Study (CHS-0214-05) [Phase 3]
Phase 3 long-term safety extension study for a therapy in rheumatoid arthritis and plaque psoriasis has completed with results posted in 201…